Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
UAE Cancer Diagnostics Market, By Product (Consumable {Antibodies, Kits & Reagents, Probes, Others} v/s Instruments {Pathology Instruments, Imaging Instruments, Biopsy Instruments}), By Technology (IVD Testing, Imaging, Biopsy), By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Others), By Region, Competition Forecast & Opportunities, 2027
... Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Others), By Region, Competition Forecast & Opportunities, 2027 The UAE cancer diagnostics market is projected to grow at a significant rate during the forecast period, 2023-2027. ... Read More
-
Pancreatic Cancer - Market Insight, Epidemiology And Market Forecast - 2032
... well as the pancreatic cancer market trends in the United States, EU-5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. The pancreatic cancer market report provides current treatment practices, emerging drugs, and market ... Read More
-
Uveal Melanoma - Pipeline Insight, 2022
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Large Granular Lymphocytic Leukemia (LGLL)- Market Insights, Epidemiology, and Market Forecast-2032
... epidemiology as well as the LGLL market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The LGLL market report provides current treatment practices, emerging drugs, LGLL market share ... Read More
-
Pancreatic Cancer - Pipeline Insight, 2022
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Immunotherapy Drugs Market Size, Share & Trends Analysis Report By Drug Type (Monoclonal Antibodies, Immunomodulators), By Indication (Infectious Diseases, Cancer), By Region, And Segment Forecasts, 2022 - 2030
... expected to grow at a CAGR of 6.92% from 2022 to 2030. The key factors contributing to the lucrative growth of the industry include increased awareness about chronic diseases including cancer, autoimmune diseases, inflammatory diseases, ... Read More
-
Pharmaceutical Contract Sales Outsourcing (CSO) Market (Therapeutic Area: Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others) - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... Outsourcing (CSO) Market – Scope of Report TMR’s report on the pharmaceutical contract sales outsourcing (CSO) market in Europe studies the past as well as the current growth trends and opportunities to gain valuable insights ... Read More
-
Pancreatic Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape. Pancreatic cancer is a disease in which malignant (cancer) cells are found in the tissues of the pancreas. This is also called exocrine cancer. Signs ... Read More
-
Gene Therapy Market by Vectors (Non-viral(Oligonucleotides), Viral(Retroviral, Adeno-associated)), Indication (Cancer, Neurological, Hepatological Diseases, Duchenne Muscular Dystrophy), Delivery Method (In Vivo, Ex Vivo), Region - Global Forecast to 2027
... at an estimated USD 7.3 billion in 2022 and is projected to reach USD 17.2 billion by 2027, at a CAGR of 18.6% during the forecast period. Factors such asrising cases of neurological diseases and ... Read More
-
Chronic Myelomonocytic Leukemia (CMML) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Chronic Myelomonocytic Leukemia (CMML) Clinical trials scenario. This report provides top line data ... Read More
-
Nasopharyngeal Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Nasopharyngeal Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Women's Health Diagnostics Market Analysis and Forecast till 2031: By Type (Diagnostic Devices, Diagnostic Tests, Accessories and Consumables), Application (Breast Cancer, Infectious Disease Testing, Osteoporosis Testing, Pregnancy and Fertility Testing, Sexually Transmitted Disease Testing), End-use (Hospitals and Clinics, Diagnostic and Imaging Centers, Homecare) and Region
... (Hospitals and Clinics, Diagnostic and Imaging Centers, Homecare) and Region The global women's health diagnostics market was valued at USD 24.8 billion in 2021 and it is anticipated to grow up to USD 49.0 billion ... Read More
-
Colorectal Cancer Screening Market, By Screening Tests (Stool-based Tests, Colonoscopy, CT Colonography (Virtual Colonoscopy), Flexible Sigmoidoscopy, and Other Screening Tests), By End User (Hospitals Independent Diagnostic Labs and Other End Users), and By Geography (North America, South America, Europe, Asia-Pacific, and Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... America, South America, Europe, Asia-Pacific, and Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Colorectal cancer is a type of cancer that begins in the large intestine (colon). The ... Read More
-
Global Liquid Biopsy Market, By Sampling Type (Blood Sampling, Urine Sampling, Saliva Sampling, and Other Tissue Fluids Sampling), By Product and Service (Assay Kits, Instruments, and Services), By Circulating Biomarker (Circulating Tumor Cells, Circulating Tumor DNA), By Clinical Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring), By Application (Cancer Applications, Non-Cancer Applications), By End User (Reference Laboratories, Hospitals, Physician Laboratories, Academic Researchers, and Others), By Region (North America, Europe, The Asia Pacific, Latin America, and The Middle East and Africa)Trend Analysis, Competitive Market Share & Forecast, 2018-2028
... DNA), By Clinical Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring), By Application (Cancer Applications, Non-Cancer Applications), By End User (Reference Laboratories, Hospitals, Physician Laboratories, Academic Researchers, and Others), By Region (North America, ... Read More
-
Pet Cancer Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... million by 2027, registering a CAGR of 8.89% from 2022 to 2027. American Veterinary Medical Association 2020, conducted a survey for practice owners wherein it was concluded that an increasing number of veterinary practices are ... Read More
-
Veterinary Oncology Market Intelligence Report - Global Forecast to 2027
... the forecast period. Market Statistics: The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange ... Read More
-
Cancer Monoclonal Antibodies Market Size, Share & Trends Analysis Report By Type (Chimeric Antibodies, Humanized Antibodies), By Application (Blood Cancer, Breast Cancer, Lung Cancer), By End-user, By Region, And Segment Forecasts, 2022 - 2030
... is expected to expand at a CAGR of 11.2% from 2022 to 2030. The increasing prevalence of cancer, and product approvals along with a robust pipeline are the key factors augmenting the market growth. Furthermore, ... Read More
-
Real-world Evidence (RWE) Solutions Market by Component (Datasets [Clinical, Claims, Pharmacy, Integrated], Services), Application (Market Access, Oncology, Neurology, Post Market Surveillance), End User - Global Forecast to 2029
... expected to grow at a CAGR of 11.8% from 2022 to 2029 to reach $4.9 billion by 2029 Following a thorough primary and secondary research and in-depth analysis of the market scenario, the report carries ... Read More
-
RWE Oncology Market by Component (Datasets [EHR, Claims, Cancer Registries], Consulting & Analytics Services), Application (Drug Development, Approval, Market Access, Post-market Surveillance), End User (Pharma, Payer) - Global Forecast to 2029
... solutions market is expected to grow at a CAGR of 14.2% from 2022–2029 to reach $1.65 billion by 2029. After a comprehensive primary and secondary research and an in-depth analysis of the market scenario, this ... Read More
-
Doxorubicin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Formulation (Lyophilized Powder and Doxorubicin Injection), Application (Breast Cancer, Kidney Cancer, Liver Cancer, Sarcoma, Ovarian Cancer, Lung Cancer, Leukemia, Multiple Myeloma, and Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy)
... Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) The global doxorubicin market is projected to reach US$ 1,983.40 million by 2028 from US$ 1,390.64 million in 2022; it is expected to register ... Read More
-
Lung Cancer Screening Market Analysis and Forecast to 2031: By Cancer Type (Non-Small Cell Lung Cancer, Small Cell Lung Cancer), End-User (Hospitals, Clinics, Diagnostic Centers), and Region
... screening that is used to look for signs of lung cancer in people who are at high risk for the disease. The goal of lung cancer screening is to find lung cancer early when it ... Read More
-
Community Oncology Services Global Market Opportunities And Strategies To 2031: COVID-19 Growth And Change
... strategists; marketers and senior management with the critical information they need to assess the global community oncology services market as it emerges from the COVID 19 shut down. Reasons to Purchase Gain a truly global ... Read More
-
Immuno-Oncology Drugs Global Market Opportunities And Strategies To 2031
... need to assess the global immuno-oncology drugs market as it emerges from the COVID 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering ... Read More
-
Clinical Laboratory Services Market Forecasts to 2028 – Global Analysis By Laboratory Type (Hospital, Commercial), Specialty (Hematology, Clinical Chemistry), Application, and By Geography
... for $219.57 billion in 2022 and is expected to reach $324.01 billion by 2028 growing at a CAGR of 6.7% during the forecast period. Clinical laboratory service is to detect and monitor the test results ... Read More
-
Global IVD Antibodies Market Size study, By Product Type (Cardiac Markers, Tumor Markers, Kidney Injury Markers, Infection and Inflammation Antibodies), By Application (Immunology, Cancer, Cardiovascular Diseases), By End User (Hospitals, Diagnostic Laboratories, Homecare Settings, Others), and Regional Forecasts 2022-2028
... and Regional Forecasts 2022-2028 Global IVD Antibodies Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period ... Read More
Research Assistance
